Anticipating Part D Phase Changes: How Heart Failure Patients Respond to the Medicare Drug Benefit Design

Background: Much has been written about the impact of the Part D coverage gap on prescription filling behavior of Medicare beneficiaries with cardiovascular disease. However, we do not know if beneficiaries anticipating gap entry also cut spending in order to delay or avoid being in the gap. Methods and Results: We tracked 16,272 pairs of Part D enrollees with heart failure from 2006 through 2008 (half with full cost-sharing and half low-income subsidy recipients) matched on characteristics predictive of future drug spending. We estimated differences between the groups in drug spending, probability of reaching the gap and catastrophic thresholds, and December/January differences in spending. The highest drug spenders (>$600 per month) were least affected by phase transitions. Among lower spenders, 2.8% to 3.8% (p<0.05) avoided the gap through anticipatory cutbacks in 2007, rising to 6.1% to 7.7% (p<0.05) in 2008. Total reductions in drug spending attributable to Part D design features were 4.4% to 8.7% in 2007 and 11.8 to 17.1% in 2008 (p<0.05). Beneficiaries deflected part of the gap impact by shifting prescription fills from December 2007 to January 2008. The Part D design had little effect on heart failure medication spending. Conclusions: Filling the Part D coverage gap under provisions of the Affordable Care Act will provide economic benefits to most heart failure patients with mid- to high-level drug spending, but the biggest effect on drug utilization is likely among beneficiaries who anticipated entry into the coverage gap under the original benefit design.

[1]  Y. Zhang,et al.  Effects of Medicare Part D coverage gap on medication adherence. , 2013, The American journal of managed care.

[2]  J. Doshi,et al.  Impact of Part D Low-income Subsidies on Medication Patterns for Medicare Beneficiaries With Diabetes , 2012, Medical care.

[3]  Robert Lee,et al.  Costs and outcomes associated with clopidogrel discontinuation in Medicare beneficiaries with acute coronary syndrome in the coverage gap , 2012, Drug, healthcare and patient safety.

[4]  Pengxiang Li,et al.  Effect of the Medicare Part D Coverage Gap on Medication Use Among Patients With Hypertension and Hyperlipidemia , 2012, Annals of Internal Medicine.

[5]  S. Schneeweiss,et al.  Beneficiaries With Cardiovascular Disease and the Part D Coverage Gap , 2012, Circulation. Cardiovascular quality and outcomes.

[6]  S. Schneeweiss,et al.  Changes in Drug Utilization during a Gap in Insurance Coverage: An Examination of the Medicare Part D Coverage Gap , 2011, PLoS medicine.

[7]  B. Patel,et al.  Part D coverage gap and adherence to diabetes medications. , 2010, The American journal of managed care.

[8]  J. Hales,et al.  How the doughnut hole affects prescription fulfillment decisions involving cardiovascular medications for Medicare Part D enrollees. , 2010, Managed care.

[9]  Y. Zhang,et al.  The Medicare drug benefit (Part D) and treatment of heart failure in older adults. , 2010, American heart journal.

[10]  W. Steers,et al.  Generic‐Only Drug Coverage in the Medicare Part D Gap and Effect on Medication Cost‐Cutting Behaviors for Patients with Diabetes Mellitus: The Translating Research into Action for Diabetes Study , 2010, Journal of the American Geriatrics Society.

[11]  C. Mangione,et al.  Falling into the coverage gap: Part D drug costs and adherence for Medicare Advantage prescription drug plan beneficiaries with diabetes. , 2010, Health services research.

[12]  A. Pedan,et al.  Assessment of drug consumption patterns for Medicare Part D patients. , 2009, The American journal of managed care.

[13]  C. Mangione,et al.  Medicare Part D coverage gap and diabetes beneficiaries. , 2009, The American journal of managed care.

[14]  J. Lave,et al.  The effects of the coverage gap on drug spending: a closer look at Medicare Part D. , 2009, Health affairs.

[15]  J. Newhouse,et al.  Medicare beneficiaries' knowledge of Part D prescription drug program benefits and responses to drug costs. , 2008, JAMA.

[16]  J. Doshi,et al.  Drug benefit generosity and essential medication use among Medicare-eligible retirees. , 2007, The American journal of managed care.

[17]  K. Nair,et al.  Comparing pre-gap and gap behaviors for Medicare beneficiaries in a Medicare managed care plan. , 2011, Journal of health care finance.